| Outcome | Magnesium | Placebo | Difference between proportions/means/locations magnesium-placebo) (95% CI); p value |
|---|---|---|---|
| Mean (SD) ASS T60; number | 4.72 (1.37) n=228 | 4.95 (1.40) n=244 | −0.25 (−0.48,−0.02); p=0.03 |
| Mean (SD) LOS (hours) | 32 (25) | 35 (27) | −2.99 (−7.55, 1.56); p=0.20 |
| Need for IV treatment (%) | 24/249 (10%) | 30/255 (12%) | −0.02 (−0.07, 0.03) p=0.53 |
| Median additional salbutamol doses given in hospital (IQ range) | 8 (4-14) | 9 (4-17) | −1.0 (−2.0, 0) p=0.24 |
| PICU or intubation (%) | 22/251 (9%) | 15/254 (6%) | 0.03 (−0.20, 0.07) p=0.28 |
| Serious adverse events | 3 | 9 | |
| Adverse events | 38 | 41 |